In 2024, Medacta Group completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, Medacta Group has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2024 | 2023 |
|---|---|---|
Total Scope 1 | 1,296a | 949a |
Total Scope 2 | ||
Market-Based | 321a | 254a |
Location-Based | 620a | 509a |
Total Scope 3 | N/A | N/A |
Total Scope 1 Revenue Intensity (tCO2e/$M) | 2.1088a | 1.6786a |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.
In 2024, the total operational greenhouse gas (GHG) emissions of Medacta Group amounted to 1,916 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
Compared to 2023, the total operational greenhouse gas (GHG) emissions of Medacta Group increased by 31.41%, suggesting that the company faced challenges in reducing its emissions from its core operations.a
In 2024, the total Scope 1 emissions of Medacta Group were 1,296 metric tons of CO₂ equivalent (tCO₂e).a
Compared to the previous year (2023), Medacta Group's Scope 1 emissions increased by 36.56%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.a
In 2024, Medacta Group reported Scope 2 greenhouse gas (GHG) emissions of 321 tCO₂e using the market-based method and 620 tCO₂e using the location-based method.a
Compared to the previous year (2023), Medacta Group's Scope 2 emissions (Location-Based) rose by 21.81% in 2024, suggesting that the company faced challenges in reducing emissions from purchased electricity and energya
In 2024, Medacta Group reported its Scope 2 emissions using the market-based method and using the location-based method.a
In 2024, Medacta Group reported Scope 1 greenhouse gas (GHG) emissions of 1,296 tCO₂e and total revenues of USD 615 millions. This translates into an emissions intensity of 2.11 tCO₂e per millions USD.a
In 2024, Medacta Group reported a Scope 1 emissions intensity of 2.11 tCO₂e per millions USD. Compared to the peer group median of 1.96, this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors.a
In 2024, Medacta Group ranked 14 out of 25 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a
Medacta Group is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency.a